Synthetic Entries to and Biological Activity of Pyrrolopyrimidines

被引：139

作者：

De Coen, Laurens M. ^{[1
]}

Heugebaert, Thomas S. A. ^{[1
]}

Garcia, Daniel ^{[1
]}

Stevens, Christian V. ^{[1
]}

机构：

[1] Univ Ghent, Dept Sustainable Organ Chem & Technol, B-9000 Ghent, Belgium

来源：

CHEMICAL REVIEWS | 2016年 / 116卷 / 01期

关键词：

PURINE NUCLEOSIDE PHOSPHORYLASE; ADENOSINE-KINASE-INHIBITORS; TRANSITION-STATE ANALOGS; SELECTIVE ALPHA(1)-ADRENOCEPTOR LIGANDS; COUPLED FOLATE TRANSPORTER; STRUCTURE-BASED DESIGN; VIRUS-RNA REPLICATION; DIELS-ALDER REACTION; ONE-POT SYNTHESIS; GYRASE B GYRB;

D O I：

10.1021/acs.chemrev.5b00483

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

This review summarizes recent literature (2000-2015) on the synthesis and pharmaceutical properties of pyrrolopyrimidines. These modified pyrimidine bases, fused to a pyrrole ring, and their corresponding nucleosides display a broad applicability in medicinal chemistry. This overview is divided into three main sections, according to the respective isomers: pyrrolo[2,3-d]pyrimidines, pyrrolo[3,2-d]pyrimidines, and pyrrolo[3,4-d]pyrimidines. Each section contains a description of common retro-synthetic strategies, with particular attention for newly reported synthetic entries to the scaffold. Next, the synthetic strategies and the ways in which the scaffolds can be further modified are exemplified according to the biological properties of the obtained products.

引用

页码：80 / 139

页数：60

共 186 条

[1] A convenient synthesis of pyrrolo[2,3-b]pyridines and pyrido[2′,3′:5,4]pyrrolo[2,3-d]pyrimidines
Abdel-Mohsen, Shawkat A.
Geies, Ahmed A.
[J]. MONATSHEFTE FUR CHEMIE, 2008, 139 (10): : 1233 - 1240
[2] Synthesis and antiviral activity of novel acyclic nucleosides in the 5-alkynyl- and 6-alkylfuro[2,3-d]pyrimidine series
Amblard, F
Aucagne, V
Guenot, P
Schinazi, RF
Agrofoglio, LA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) : 1239 - 1248
[3] Tasocitinib
不详
[J]. Drugs in R & D, 2010, 10 (4) : 271 - 284
[4] Novel Compounds with a Viologen Skeleton and N-Heterocycles on the Peripheries: Electrochemical and Spectroscopic Properties
Asaftei, Simona
Lepadatu, Ana Maria
Ciobanu, Marius
[J]. HELVETICA CHIMICA ACTA, 2011, 94 (06) : 1091 - 1101
[5] Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor
Aso, Kazuyoshi
Kobayashi, Katsumi
Mochizuki, Michiyo
Kanzaki, Naoyuki
Sako, Yuu
Yano, Takahiko
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2365 - 2371
[6] Highly efficient AgNO3-catalyzed preparation of substituted furanopyrimidine nucleosides
Aucagne, V
Amblard, F
Agrofoglio, LA
[J]. SYNLETT, 2004, (13) : 2406 - 2408
[7] The Methylation Effect in Medicinal Chemistry
Barreiro, Eliezer J.
Kuemmerle, Arthur E.
Fraga, Carlos A. M.
[J]. CHEMICAL REVIEWS, 2011, 111 (09) : 5215 - 5246
[8] Batcho A.D., 1985, Org. Synth, V63, P214, DOI DOI 10.15227/orgsyn.063.0214
[9] Practical synthesis of a potent hepatitis C virus RNA replication inhibitor
Bio, MM
Xu, F
Waters, M
Williams, JM
Savary, KA
Cowden, CJ
Yang, CH
Buck, E
Song, ZGJ
Tschaen, DM
Volante, RP
Reamer, RA
Grabowski, EJJ
[J]. JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (19) : 6257 - 6266
[10] Adenosine kinase inhibitors.: 6.: Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds
Bookser, BC
Ugarkar, BG
Matelich, MC
Lemus, RH
Allan, M
Tsuchiya, M
Nakane, M
Nagahisa, A
Wiesner, JB
Erion, MD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) : 7808 - 7820

← 1 2 3 4 5 6 7 8 9 10 →